Results 81 to 90 of about 4,333 (173)

G6f-like is an ITAM-containing collagen receptor in thrombocytes.

open access: yesPLoS ONE, 2012
Collagen activates mammalian platelets through a complex of the immunoglobulin (Ig) receptor GPVI and the Fc receptor γ-chain, which has an immunoreceptor tyrosine-based activation motif (ITAM).
Craig E Hughes   +6 more
doaj   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Functional characterization of a nanobody-based glycoprotein VI-specific platelet agonist

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: Glycoprotein (GP)VI is a platelet-specific collagen receptor required for platelet activation during hemostasis. Platelet reactivity toward collagen is routinely assessed during diagnostic workup of platelet disorders.
Minka Zivkovic   +74 more
doaj   +1 more source

Clustering of GPVI dimers upon adhesion to collagen as a mechanism to regulate GPVI signalling in platelets [PDF]

open access: yes, 2017
Background: Platelet GPVI binding to subendothelial collagen exposed upon blood vessel injury initiates thrombus formation. Dimeric GPVI has high affinity for collagen and occurs constitutively on resting platelets. Objective: To identify higher order oligomerisation (clustering) of pre-existing GPVI-dimers upon interaction with collagen as a mechanism
Poulter, N. S.   +11 more
openaire  

Mechanism of Buyang Huanwu Decoction in Improving Heart Failure after Myocardial Infarction by Inhibiting Platelet Aggregation via Platelet Glycoprotein VI: An Investigation Based on Molecular Docking and Surface Plasmon Resonance

open access: yesWorld Journal of Traditional Chinese Medicine
Objective: Postmyocardial infarction heart failure (HF post-MI) induces platelet disorders, increased blood viscosity, and thrombosis. Buyang Huanwu decoction (BHD), a classical Chinese formulation for Qi deficiency and blood stasis, has proven clinical ...
Zi-Yan Wang   +11 more
doaj   +1 more source

GPVI inhibition: Advancing antithrombotic therapy in cardiovascular disease

open access: yesEuropean Heart Journal - Cardiovascular Pharmacotherapy
Abstract Glycoprotein (GP) VI (GPVI) plays a major role in thrombosis but not haemostasis, making it a promising antithrombotic target. The primary role of GPVI on the surface of platelets is a signalling receptor for collagen, which is one of the most potent thrombotic sub-endothelial components that is exposed by atherosclerotic plaque
Alexandre Slater   +2 more
openaire   +2 more sources

OC 58.3 Affinity of anti-GPVI Antibodies Determines the Degree of Human and Mouse GPVI Depletion in vivo

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2023
S. Navarro   +5 more
openaire   +1 more source

Characterization of Platelet Protein Alterations in Stored Platelet Concentrates. [PDF]

open access: yesJ Clin Med
Alhawiti NM   +4 more
europepmc   +1 more source

Receptor homodimerization significantly prolongs the lifetime of ligand-induced cross-linking of CLEC-2 but not GPVI. [PDF]

open access: yesBlood Vessel Thromb Hemost
Clark JC   +5 more
europepmc   +1 more source

Research advances on platelet glycoprotein VI in ischemic stroke. [PDF]

open access: yesThromb J
Xiang H   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy